Status:

UNKNOWN

Efficacy of Transcranial Direct Current Stimulation (tDCS) for the Treatment of Major Depressive Disorder

Lead Sponsor:

Tianjin Anding Hospital

Conditions:

Major Depressive Disorders

Eligibility:

All Genders

18-50 years

Phase:

NA

Brief Summary

The aim of this study is to assess the efficacy of Transcranial Direct Current Stimulation (tDCS) as an Add-on Treatment for the drug-naïve Major depressive disorder. Meanwhile, evaluate the effect of...

Detailed Description

This is a randomized, double-blind, sham-controlled study using transcranial Direct Current Stimulation (tDCS) for 4-week treatment. After the intervention of tDCS, there is a follow up visit at week ...

Eligibility Criteria

Inclusion

  • a current episode of MDD diagnosed according to Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)
  • age between 18 and 50 years
  • a total score of HAMD-17 ≥ 17
  • take antidepressants less than 3 days
  • Patients are compliant with treatment according to the judgement of the treating clinician.
  • Participant or guardian has to sign informed consent. The patients' guardians will sign the informed consent on behalf of the participants when the capacity of participants to consent is compromised.

Exclusion

  • A history of manic episode
  • Use of mood stabilizer
  • History of substance abuse or dependence
  • Severe somatic diseases that might interfere with regular antidepressant treatment including conditions such as kidney and liver failure, uncontrolled hypertension, cardiovascular, cerebrovascular and pulmonary disease, thyroid disease, diabetes, epilepsy and asthma.
  • Use of anti-inflammatory medication for longer than 7 days in the last two months preceding the trial
  • Use of immunosuppressive medication such as oral steroid hormones Women in pregnancy or lactation period

Key Trial Info

Start Date :

May 22 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2023

Estimated Enrollment :

75 Patients enrolled

Trial Details

Trial ID

NCT04497493

Start Date

May 22 2020

End Date

March 1 2023

Last Update

October 19 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Tianjin Anding Hospital

Tianjin, China